Effect of fatty acids on estradiol and testosterone binding to whole DU-145 prostate cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 4, 2002, Pages 419-425

  Prinsloo, S E ^a   Van Aswegen, C H ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANDROGEN RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; FATTY ACID DERIVATIVE; ICOSAPENTAENOIC ACID; LINOLENIC ACID; TESTOSTERONE; FATTY ACID;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; PRIORITY JOURNAL; PROSTATE CARCINOMA; CELL ADHESION; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; MALE; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

CELL ADHESION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FATTY ACIDS; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; TESTOSTERONE; TUMOR CELLS, CULTURED;

EID: 0035989495     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0368     Document Type: Article

References (49)

1. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy
2. Defeating prostate cancer: Crucial directions for research-excerpt from the report of the prostate cancer progress review group
3. Pathway to carcinogenesis: The role of bacteria
4. The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer
5. Uncovering new clues to cancer risk
6. Diet, androgens, oxidative stress and prostate cancer susceptibility
7. Using the Health Belief Model in understanding prostate cancer in African American men
8. Nutritional and socioeconomic in relation to prostate cancer mortality: A cross-national study
9. Monoclonal antibodies localized oestrogen receptor in the nuclei of target cells
10. Nuclear localization of unoccupied oestrogen receptors
11. Androgen receptor levels and androgen contents in the prostate lobes of intact and testosterone-treated noble rats
12. Androgen signal transduction and prostatic carcinoma
13. Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer
14. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma
15. Androgen receptor gene and hormonal therapy failure of prostate cancer
16. Binding of estradiol to whole prostatic DU-145 cells in the presence and absence of tamoxifen and acetylsalicylic acid
17. Androgen receptor gene amplification: A novel molecular mechanism for endrocrine therapy resistance in human prostate cancer
18. Hyperactive androgen receptor in prostate cancer: What does it mean for new therapy concepts?
19. Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors
20. Expression of estrogen receptor in deseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry
21. Estrogen and progestin receptors in human prostatic carcinoma
22. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue
23. Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors
24. Prostate cancer in the African American: Is this a different disease?
25. Timing of dietary fat exposure and mammary tumorigenesis: Role of estrogen receptor and protein kianase C activity
26. Garlic, onion and cereal fibre as protective factors for breast cancer: A French case-control study
27. Prostate cancer
28. The conditional nature of the dietary need for polyunsaturates: A proposal to reclassify 'essential fatty acids' as 'conditionally-indispensable' or 'conditionally-dispensable' fatty acids
29. 1 on the proliferation of human osteogenic sarcoma cells in culture
30. Gamma-linolenic acid, arachidonic acid, and eicosapentaenoic acid as potential anticancer drugs
31. 1 on three human colon carcinoma cell lines
32. Essential fatty acids, lipid peroxidation, and cancer
33. Cancer
34. Unsaturated lipids and cancer
35. Androgen binding as evidenced by a whole cell assay system using cultured canine prostatic epithelial cells
36. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
37. Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wildtype estrogen receptor in ovarion carcinomas
38. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis
39. Stimulation of human monocyte β-glucan receptor by glucan particles induces production of the TNF-α and IL-1β
40. Chemiluminescent detection of mRNAs on Northern blots with Digoxigenin end-labeled oligonucleotides
41. Timing of dietary fat exposure and mammary tumorigenesis: Role of estrogen receptor and protein kinase C activity
42. Membrane fatty acid modification in tumor cells: A potential therapeutic adjunt
43. Regulation of tight junction permeability and occluding expression by polyunsaturated fatty acids
44. Identification and characterization of membrane estrogen receptor from MCF-7 estrogen-target cells
45. Diet, androgens, oxidative stress and prostate cancer susceptibility
46. Tumour markers in prostate cancer: EGTM recommendations
47. Blood and serum substances for markers of prostate cancer
48. The evolving role of hormone therapy in advanced prostate cancer
49. Signaling for the caspases: Their role in prostate cell apoptosis